These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4771148)

  • 1. [Antiparkinson drugs--abuse among youth].
    Retterstol N
    Tidsskr Nor Laegeforen; 1973 Nov; 93(31):2332. PubMed ID: 4771148
    [No Abstract]   [Full Text] [Related]  

  • 2. Abuse of the antiparkinson drugs: a review of the literature.
    Smith JM
    J Clin Psychiatry; 1980 Oct; 41(10):351-4. PubMed ID: 7430078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Letter: Intoxicating abuse of antiparkinson drugs].
    Hartvig P
    Tidsskr Nor Laegeforen; 1973 May; 93(13):957. PubMed ID: 4751597
    [No Abstract]   [Full Text] [Related]  

  • 4. [Abuse of antiparkinsonian drugs among psychiatric patients].
    Haggag A; Nissen T; Småbrekke A; Bratlid T
    Tidsskr Nor Laegeforen; 1986 Nov; 106(32):2734-6, 2753. PubMed ID: 3810596
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
    Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
    J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease].
    Kuiper MA; Zwaan WA; Wolters EC
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892
    [No Abstract]   [Full Text] [Related]  

  • 7. Levodopa dependence and abuse in Parkinson's disease.
    Spigset O; von Schéele C
    Pharmacotherapy; 1997; 17(5):1027-30. PubMed ID: 9324193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Personal and socio-cultural phenomenon of narcotic abuse in youth. (Also a contribution on phenomenological psychopatholgy of addiction)].
    Gastager H
    Z Klin Psychol Psychother; 1973; 21(1):54-64. PubMed ID: 4804559
    [No Abstract]   [Full Text] [Related]  

  • 9. The comorbidity of substance abuse and depressive symptoms in Costa Rican adolescents.
    Obando P; Kliewer W; Murrelle L; Svikis DS
    Drug Alcohol Depend; 2004 Oct; 76(1):37-44. PubMed ID: 15380287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse by youth and young adults in rural America.
    Lambert D; Gale JA; Hartley D
    J Rural Health; 2008; 24(3):221-8. PubMed ID: 18643798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drugs used by addicts].
    Poirier MF
    Soins Psychiatr; 1988; (94-95):9-11. PubMed ID: 3187625
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drugs diverted from reaching drug addicts].
    Poirier MF; Ginestet D
    Rev Prat; 1995 Jun; 45(11):1364-6. PubMed ID: 7659984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tactile hallucinations induced by trihexyphenidyl in a patient with Parkinson's disease].
    Funakawa I; Jinnai K
    Rinsho Shinkeigaku; 2005 Feb; 45(2):125-7. PubMed ID: 15782612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Youth and drugs--use and abuse. Educational and sociological aspects.
    Forsythe MJ
    Ohio State Med J; 1969 Jan; 65(1):17-23. PubMed ID: 5812524
    [No Abstract]   [Full Text] [Related]  

  • 15. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of relapse to substance use in comorbid adolescents.
    Ramo DE; Anderson KG; Tate SR; Brown SA
    Addict Behav; 2005 Oct; 30(9):1811-23. PubMed ID: 16139961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Toxic and adverse neurological effects of anti-parkinsonian drugs].
    Sunohara N
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715
    [No Abstract]   [Full Text] [Related]  

  • 18. Substance use in maltreated youth: findings from the national survey of child and adolescent well-being.
    Wall AE; Kohl PL
    Child Maltreat; 2007 Feb; 12(1):20-30. PubMed ID: 17218645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Features associated with the development of hallucinations in Parkinson's disease.
    Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
    Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Youth substance use and abuse: challenges and strategies for identification and intervention.
    Leslie K
    CMAJ; 2008 Jan; 178(2):145-8. PubMed ID: 18195284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.